The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
about
RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonistIL-6 polymorphisms: a useful genetic tool for inflammation research?Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during InflammationThe Role of Dietary Inflammatory Index in Cardiovascular Disease, Metabolic Syndrome and MortalityFlavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesPrecision medicine in myasthenia graves: begin from the data precisionFrom C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionInnate and adaptive immunity in the development of depression: An update on current knowledge and technological advancesC-reactive protein and coronary heart disease: all said--is not it?Mendelian randomization studies: a review of the approaches used and the quality of reportingInflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisMendelian randomization: genetic anchors for causal inference in epidemiological studiesGenome-wide association studies of late-onset cardiovascular diseaseAssociation between serum interleukin-6 concentration and mortality in patients with coronary artery diseaseManaging cardiovascular risk in patients with inflammatory arthritis: practical considerationsMendelian Randomization and Type 2 DiabetesProteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-GlycosylationTYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traitsInvestigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization StudyMendelian randomization in cardiometabolic disease: challenges in evaluating causality.The Role of Emerging Risk Factors in Cardiovascular OutcomesInflammation modulation and cardiovascular disease prevention.High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseasesBest (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.Job strain and cardiovascular disease risk factors: meta-analysis of individual-participant data from 47,000 men and women.Mendelian randomization analysis with multiple genetic variants using summarized data.Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.Interleukin-6 receptor rs7529229 T/C polymorphism is associated with left main coronary artery disease phenotype in a Chinese population.The joint effect of sleep duration and disturbed sleep on cause-specific mortality: results from the Whitehall II cohort studyNeutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma.Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension.Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".An association study between genetic polymorphism in the interleukin-6 receptor gene and coronary heart disease.Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure.Fish Oil Supplementation Reduces Heart Levels of Interleukin-6 in Rats with Chronic Inflammation due to EpilepsyProthrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood.
P2860
Q21132391-4037A951-9DE5-4126-BED3-2AAC6CF67274Q24288994-C0CEC08C-6506-41EB-ADC5-0AD1424297B9Q26738992-ECA5A70F-6A92-450E-AE4D-78C1B7BFFF06Q26741434-F615C038-4815-4D8B-B5DC-0B18A7F6BEA0Q26746303-70FC441B-56CE-4B44-A080-5C3DBBEA223EQ26747251-0C937CF1-2970-46F0-88CB-0A44ED9BB410Q26748943-81A3162E-1952-4606-8588-DCFC05CA156DQ26770209-E9A4A6A1-9718-494D-9BB4-631DDB21CF24Q26775316-DCCC65B0-D4C4-4D23-84D4-EF0254EE5F9AQ26860959-75591819-529E-4764-842B-EB24FC612284Q26999349-8A4F0AA1-092D-4330-A739-573745946A13Q27001736-66C9E813-927B-45CF-8011-B321DFFF4171Q27002487-2EDE7CE1-A2B1-4EBD-BDD9-93B25BDB440BQ27012711-A3D991D3-43B4-4D4C-90AC-E26096E74691Q27023903-E4221B12-E055-445E-9C61-E76BF32F14E3Q27694518-CCEA707C-0D3E-4488-8DC9-392F76577D69Q28072229-0C358D63-DAFF-4E01-A339-03EDB99C27A2Q28468416-6AED1611-F2CA-494E-95A7-68038D040B63Q28545832-4C03EC7E-BB08-47C5-80DB-4B3B2C286DAEQ28600936-B459EBA5-2DFE-41F2-B9E7-D3D45D211822Q30234302-E87081A7-9E5E-4830-BD9A-4EF655EC05F2Q30234550-5D0B5F39-61B4-4B69-9265-E50F7C56530DQ30361151-A673700F-9CCB-4D9E-A299-753648DC1286Q30419111-052B29F0-0421-42EA-985E-2EEFC0739CDEQ30419941-4C8E1D9F-B59D-48DE-ABD6-7E1987FC07BCQ30489063-A29BE227-DF1A-474F-B290-401B080E1BCEQ30654384-DB983D9A-EF9E-4E2E-8F99-B36691FFC73BQ30675247-F19B260A-2687-4D2C-8F6C-2BFAC3C32597Q30910636-E736353A-6015-4B4D-9B22-DA728F0A2763Q31133324-DC86FEF4-356E-457F-B146-134A0F31B5BFQ31155261-FC4437F1-8B66-4658-83C5-E6DD33D2CDBBQ31155877-B5097977-2A5A-4251-9BD4-DFEFE5A0F145Q33569149-CCAE1211-8F6C-47E6-95A5-9D6B95A44472Q33570959-832110BC-CA54-48B8-B774-80B32598A359Q33594507-33C7AD89-8FAA-41FD-A52D-C0414C90BBDFQ33611989-5C449FE1-710B-402A-B57D-C40C54D2F824Q33757566-5B929B13-3BEE-49BF-A73A-E97BF6BEFFE5Q33765836-3F03EB16-1BE3-4B7D-A00A-CC0430408C25Q33780567-02AB9F16-5EDA-49F7-A39A-0051EE42A024Q33862178-95D3D188-4B93-41EB-8BC0-EBAA4761BE56
P2860
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The interleukin-6 receptor as ...... ndelian randomisation analysis
@ast
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en-gb
type
label
The interleukin-6 receptor as ...... ndelian randomisation analysis
@ast
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en-gb
prefLabel
The interleukin-6 receptor as ...... ndelian randomisation analysis
@ast
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en-gb
P2093
P2860
P50
P1433
P1476
The interleukin-6 receptor as ...... ndelian randomisation analysis
@en
P2093
Abdonas Tamosiunas
Alex P Reiner
Andrzej Pajak
Anke-Hilse Mailand-van der Zee
Anthonius de Boer
Berta Almoguera Castillo
Brendan J Keating
Charles B Eaton
Christina Chung
Christina L Wassel
P2860
P304
P356
10.1016/S0140-6736(12)60110-X
P407
P50
P577
2012-03-14T00:00:00Z